ALK is a global company with a rich history of over 100 years in providing allergy solutions. The company addresses the growing need for allergy treatments, with a focus on respiratory allergies, food allergies, and allergic rhinitis. ALK operates production sites in Denmark, France, Spain, and the United States, and employs around 2,900 people worldwide. Their mission, Allergy+, aims to help more people with more efficient solutions.
Founded in 1923 in Copenhagen, ALK has built a strong heritage in long-term allergy treatment. The company's global headquarters is located in Hørsholm, north of Copenhagen. ALK's commitment to innovation and operational excellence positions it as a leader in the allergy treatment market.
ALK's extensive presence and expertise in allergy solutions make it a key player in the healthcare industry. Their dedication to improving the lives of those affected by allergies is evident in their continuous efforts to develop new and effective treatments.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Public Company |
| Stock ALK (NYSE) |
B2B professionals should contact ALK for partnerships in allergy treatment solutions, vendor opportunities in healthcare, and potential collaborations in innovative allergy research. ALK's extensive experience and global presence make it a valuable partner for companies looking to expand their offerings in the allergy treatment market.
Sales teams selling healthcare products, recruiters seeking roles in pharmaceutical and biotechnology, and partners offering innovative medical solutions should reach out to ALK. The company's expertise in allergy treatment and its commitment to improving patient outcomes make it an attractive partner for professionals in the healthcare industry.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with ALK